Expert Opinion on Vaccination of Travelers Against Japanese Encephalitis

Burchard, Gerd; Caumes, Éric; Connor, Bradley A.; Freedman, David O.; Jelı́nek, Tomáš; Jong, Elaine C.; Sonnenburg, Frank von; Steffen, Robert; Tsai, Theodore F.; Wilder‐Smith, Annelies; Zuckerman, Jane N.

doi:10.1111/j.1708-8305.2009.00330.x

Cited by 56 publications

(43 citation statements)

References 89 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Actualmente, la única vacuna disponible en España es Ixiaro® (virus entero inactivado, absorbida) 57,59 . La autorización de revacunaciones posteriores aún no ha sido establecida.…”

Section: Consideraciones De Edad: Vacuna De Encefalitis Japonesaunclassified

Ellos también viajan

García

2013

Rev Pediatr Aten Primaria

View full text Add to dashboard Cite

Child Travellers CountThe World Tourism Organization estimates that in 2013 tourism will continue growing and that in 2020 there will be 1.6 billion international trips taken. In 2011, there were 13.3 million trips taken abroad in Spain. There are very few figures for the number of international trips taken by Spanish children, but it is known that they form about 10% of travellers, a similar percentage to that found in US studies. Furthermore, during the last decade the immigrant population of Spain has grown, increasing the number of families returning to their home country to visit friends and relations. Although children make up a significant proportion of international travellers there is little information on pre-travel medicine for this group. The aim of this article is to describe the particularities of general advice, vaccination recommendations and malaria prevention for child international travellers, with the purpose of both infectious and non-infectious disease prevention.La Organización Mundial del Turismo estima que en el año 2013 el turismo continuará creciendo y que en el año 2020 los viajes internacionales van a ser 1,6 billones. En 2011 se realizaron en España 13,3 millones de viajes al extranjero. Las estimaciones de niños españoles que realizan un viaje internacional son muy escasas, pero se sabe que estos representan aproximadamente un 10% de los viajeros, porcentaje parecido al mencionado en estudios realizados en EE. UU. Además, en la última década en España ha aumentado la población inmigrante, lo que incrementa el número de familias que retornan a sus países de origen para visitar a sus amigos y familiares. Aunque los niños representan una parte importante de los viajeros internacionales, existe poca información acerca de la medicina previaje en este grupo de población. El objetivo de este artículo es describir las particularidades, en el niño que realiza un viaje internacional, de los consejos generales y las recomendaciones de vacunación y prevención de la malaria; se pretende prevenir no solo las enfermedades infecciosas, sino también las no infecciosas. Key words: . Además, en la última década en España se ha incrementado la población inmigrante, lo que aumenta el número de familias que retornan a sus países de origen para visitar a

show abstract

“…Actualmente, la única vacuna disponible en España es Ixiaro® (virus entero inactivado, absorbida) 57,59 . La autorización de revacunaciones posteriores aún no ha sido establecida.…”

Section: Consideraciones De Edad: Vacuna De Encefalitis Japonesaunclassified

Ellos también viajan

García

2013

Rev Pediatr Aten Primaria

View full text Add to dashboard Cite

show abstract

“…angioedema) [48]. The discontinued availability of the mouse brain-derived vaccine and licensure of a new, well-tolerated cell-culture-derived vaccine IC51 with an excellent safety profile, justifies the reconsideration of the benefit-risk ratio of vaccination of travelers in order to prevent the occurrence of severe, but vaccinepreventable JE cases [48]. These considerations are reflected in revised recommendations (March 2010) by the United States Advisory Committee on Immunization Practices [9].…”

Section: Prevention Of Infectionmentioning

confidence: 99%

“…encephalitis, encephalopathy, seizures and peripheral neuropathy) and hypersensitivity side effects (e.g. angioedema) [48]. The discontinued availability of the mouse brain-derived vaccine and licensure of a new, well-tolerated cell-culture-derived vaccine IC51 with an excellent safety profile, justifies the reconsideration of the benefit-risk ratio of vaccination of travelers in order to prevent the occurrence of severe, but vaccinepreventable JE cases [48].…”

Section: Prevention Of Infectionmentioning

confidence: 99%

“…Furthermore, travelers should be advised about the risks of JEV infection and characteristics of available vaccines [48] (Table 2). Factors to consider when evaluating a traveler's risk for JEV exposure before JE vaccination are described on Table 2 [9,48]. Other factors to be taken into account include age (individuals ≥ 50 and children ≤ 10 years of age are at increased risk for serious morbidity and death), and individuals with chronic conditions such as hypertension, diabetes mellitus, chronic renal disease, solid organ transplant, central nervous system devices, and cerebrospinal fluid leakage [4,9,48].…”

Section: Prevention Of Infectionmentioning

confidence: 99%

“…Revised recommendations include vaccination with JE vaccine for travelers visiting areas of Asia endemic for JE who will be in a high-risk setting based on season, location, duration, and activities [9]. Furthermore, travelers should be advised about the risks of JEV infection and characteristics of available vaccines [48] (Table 2). Factors to consider when evaluating a traveler's risk for JEV exposure before JE vaccination are described on Table 2 [9,48].…”

Section: Prevention Of Infectionmentioning

confidence: 99%

See 2 more Smart Citations

Travel-acquired Japanese encephalitis and vaccination considerations

Pavli

Maltezou

2015

J Infect Dev Ctries

View full text Add to dashboard Cite

Japanese encephalitis (JE) is a serious arboviral disease caused by a virus of the genus Flavivirus. Japanese encephalitis is the most common vaccine-preventable virus causing encephalitis in Asia, affecting more than 50,000 persons and leading to 15,000 fatalities per year in endemic countries. For most travelers to Asia, the risk of Japanese encephalitis infection is extremely low and depends on destination, duration of travel, season, and activities. This article reviews travel-acquired Japanese encephalitis with a focus on epidemiology and prevention in the light of the newly available options for active immunization against Japanese encephalitis which have become available, and of the increasing popularity of travels to Japanese encephalitis endemic countries.

show abstract